Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies

Haematologica

Volumn 96, Issue 1, 2011, Pages

  Trecarichi, Enrico Maria ^a   Tumbarello, Mario ^a   Caira, Morena ^a   Candoni, Anna ^b   Cattaneo, Chiara ^c   Pastore, Domenico ^d   Fanci, Rosa ^e   Nosari, Annamaria ^f   Vianelli, Nicola ^g   Busca, Alessandro ^h   Spadea, Antonio ⁱ   Pagano, Livio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UO Ematologia   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h MOLINETTE HOSPITAL   (Italy)

ⁱ REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Bacterial infections; Empiric antibiotic therapy; Neutropenia

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; DRUG USE; HEMATOLOGIC MALIGNANCY; HUMAN; INDWELLING CATHETER; ITALY; LETTER; MORTALITY; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TERTIARY HEALTH CARE;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78650974097     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.036640     Document Type: Letter

References (8)

1. Caselli D, Cesaro S, Ziino O, Zanazzo G, Manicone R, Livadiotti S, et al. Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. Haematologica. 2010;95(9):1612-5.
2. Lodise TP Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51(10):3510-5.
3. Giske CG, Monnet DL, Cars O, Carmeli Y; ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813-21.
4. Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer. 2010;116(4):967-73.
5. Tumbarello M, Spanu T, Caira M, Trecarichi EM, Laurenti L, Montuori E, et al. Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis. 2009;64(3):320-6.
6. Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, et al. Incidence and clinical impact of extended-spectrum- beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect. 2009;58(4):299-307.
7. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase- producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother. 2007;51(6):1987-94.
8. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34(6):730-51.